Physician profile
Peter J Lund
NPI 1689654311
$3,005.92
in general payments reported to CMS, 2019-2025
25 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $184 · 2021: $214 · 2022: $1,515 · 2023: $130 · 2024: $348 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $1,207.00 | 2022 | |
| Innovation Technologies INC | $391.01 | 2022-2025 | Irrisept |
| Endo Pharmaceuticals INC. | $284.59 | 2019-2024 | Xiaflex |
| Horizon Therapeutics Plc | $280.30 | 2019-2022 | |
| Smith+Nephew, INC. | $134.86 | 2019-2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, "Acticoat 4"" X 4""", Grafix |
| Globus Medical, INC. | $103.87 | 2024 | Distal Radius II, Nextgen Headless Screws, Mini Fragment System |
| Linvatec Corporation | $74.24 | 2022-2023 | Biobrace 23mm, Allograft Tissue |
| Djo, LLC | $69.53 | 2023-2025 | Cmf |
| Endo USA, INC. | $65.23 | 2024-2025 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $47.02 | 2020-2024 | Zilretta, Iovera, Exparel |
| Vericel Corporation | $40.04 | 2019-2022 | |
| Axogen | $38.73 | 2019-2025 | |
| Medartis INC. | $34.37 | 2019 | |
| Medtronic, INC. | $30.95 | 2021 | |
| Depuy Synthes Sales INC. | $27.70 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $23.70 | 2021-2023 | Physio-Stim |
| Kowa Pharmaceuticals America, INC. | $21.01 | 2023 | Seglentis |
| Ipsen Biopharmaceuticals, INC | $19.34 | 2023 | Dysport |
| Nalu Medical, INC. | $18.95 | 2024 | Nalu Neurostimulation System |
| Heron Therapeutics, INC. | $17.96 | 2021 | |
| Abbott Laboratories | $17.01 | 2022 | |
| Sonex Health, INC. | $16.54 | 2024 | Sx-One Microknife |
| Abbvie INC. | $15.20 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.05 | 2024 | Strensiq |
| Pacira Therapeutics, INC. | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.